LES PUBLICATIONS. Belouzard S. Mécanismes d entrée des coronavirus. Virologie, 2010, 14:1-15.

Size: px
Start display at page:

Download "LES PUBLICATIONS. Belouzard S. Mécanismes d entrée des coronavirus. Virologie, 2010, 14:1-15."

Transcription

1 LES PUBLICATIONS MOLECULAR AND CELLULAR VIROLOGY OF HEPATITIS Inserm U CNRS UMR 8204 University Lille 1 - University Lille 2 Institut Pasteur de Lille affiliated to IFR 142 Responsable Jean DUBUISSON Ahmed-Belkacem A, Ahnou N, Barbotte L, Wychowski C, Pallier C, Brillet R, Pohl RT, Pawlotsky JM. Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase. Gastroenterology, 2010, 38: Belouzard S. Mécanismes d entrée des coronavirus. Virologie, 2010, 14:1-15. Belouzard S, Madu I, Whittaker GR. Elastase activation of the SARS coronavirus spike protein at discrete sites within S2 domain. J Biol Chem, 285: Ciczora I, Callens N, Séron K, Rouillé Y, Dubuisson J. Identification of a dominant endoplasmic reticulum retention signal in yellow fever virus pre-membrane protein. J Gen Virol, 2010, 91: Goueslain L, Alsaleh K, Horrelou P, Roingeard P, Descamps V, Duverlie G, Ciczora Y, Wychowski C, Dubuisson J, and Rouillé Y. Identification of GBF1 as a cellular factor required for HCV RNA replication. J Virol, 2010, 84: Helle F, Vieyres G, Elkrief L, Popescu I, Wychowski C, Descamps V, Castelain S, Duverlie G, Dubuisson J. Role of N-linked glycans in the functions of HCV envelope proteins incorporated into infectious virions. J Virol, 2010, in press. Montserret R, Saint N, Vanbelle C, Salvay A, Simorre JP, Ebel C, Sapay N, Renisio JG, Böckmann A, Steinmann E, Pietschmann T, Dubuisson J, Chipot C, Penin F. NMR structure analysis and ion channel activity of the p7 polypeptide from hepatitis C virus. J Biol Chem, 2010, in press. Pawlotsky JM, Cocquerel L, Durantel D, Lavillette D, Lerat H, Pécheur EI, Polyak SJ, Tautz N, Thimme R. HCV research 20 years after discovery : a summary of the 16th international meeting on hepatitis c virus and related viruses. Gastroenterology, 2010, 138:6-12. Popescu CI, Dubuisson J. Role of lipid metabolism in hepatitis C virus assembly and entry. Biol Cell, 2010, 102: Tews B, Popescu CI, Dubuisson J. Last stop before exit Hepatitis C assembly and release as antiviral drug targets. Viruses, 2010, 2: Vieyres G, Thomas X, Descamps V, Duverlie G, Patel AH, Dubuisson J. Characterization of the envelope glycoproteins associated with infectious hepatitis C virus. J Virol, 2010, 84:

2 2009 Alvarez-Lajonchere L, Shoukry N, Gra B, Amado-Canizares Y, Helle F, Bedard N, Guerra I, Drouin C, Dubuisson J, Gonzalez Horta EE, Martinez G, Marante J, Cinza Z, Castellanos M, Duenas-Carrera S. Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a phase I clinical trial. J Viral Hepatitis, 2009, 16: Charrin S, Yalaoui S, Bartosch B, Cocquerel L, Franetich JF, BoucheixC, Mazier D, Rubinstein E, Silvie O. The IG domain protein CD9P-1 down-regulates CD81 ability to support plasmodium YOELII infection. J Biol Chem, 2009, 284: Dubois A, Francois C, Descamps V, Fournier C, Wychowski C, Dubuisson J, Castelain S, Duverlie G. Enhanced anti-hcv activity of interferon alpha 17 subtype. Virol J, 2009, 6:70. Helle F, Dubuisson J. Rôle des N-glycanes dans les fonctions des protéines d enveloppe du virus de l hépatite C. Virologie, 2009, 13: Kuzmina TI, Olenina LV, Sanzhakov MA, Farafonova TE, Abramihina TV, Dubuisson J, Sobolev BN, Kolesanova EF. Antigenicity and B-epitope mapping of hepatitis C virus envelope protein E2. Biomed Chem (Moscow), 2009, 55: Rocha-Perugini V, Lavie M, Delgrange D, Canton J, Pillez A, Potel J, Lecoeur C, Rubinstein E, Dubuisson J, Wychowski C, Cocquerel L. The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C Virus entry. BMC Microbiol, 2009, 9:111. Roohvand F, Maillard P, Lavergne JP, Boulant S, Walic M, Andréo U, Goueslain L, Helle F, McLauchlan J, Budkowska A. Initiation of hepatitis C virus infection requires the dynamic microtubule network: Role of the viral nucleocapsid protein. J Biol Chem, 2009, 284: Tews BA, Cocquerel L. Occludin, an additional key for hepatitis C virus entry. Med Sci (Paris), 2009, 25: Tews BA, Dubuisson J. Occludin, the final essential factor for HCV entry? Future Virology, 2009, 4: Touvier T, Conte-Auriol F, Briand O, Cudejko C, Paumelle R, Caron S, Baugé E, Rouillé Y, Salles JP, Staels B, Bailleul B. LEPROT and LEPROTL1 cooperatively decrease hepatic growth hormone action in mice. J Clin Invest, 2009, 119 : Vieyres G, Angus AG, Haberstroh A, Baumert TF, Dubuisson J, Patel AH. Rapid synchronization of hepatitis C virus infection by magnetic adsorption. J Virol Methods, 2009, 157(1): Castelain S, Schnuriger A, François C, Nguyen-Khac E, Fournier C, Schmit JL, Capron D, Dubuisson J, Wychowski C, Thibault V, Duverlie G. Lower levels of HCV neutralizing antibodies in HIV/HCV-coinfected patients than in HCV-monoinfected patients. J Infect Dis, 2008, 198 : Dubuisson J, Helle F, Cocquerel L. Early steps of the Hepatitis C Virus life cycle. Cell Microbiol, 2008, 10:

3 Helle F, Dubuisson J. Hepatitis C Virus entry into host cells. Cell Mol Life Sci, 2008, 65: Helle F, Dubuisson J. Mechanism and inhibition of Hepatitis C Virus entry. J Viral Entry, 2008, 3: Helle F, Cocquerel L. L entrée du virus de l hépatite C dans ses cellules cibles. Virologie, 2008, 12: Jaffrelo L, Chabas S, Reigadas S, Pflieger A, Wychowski C, Rumi J, Ventura M, Toulmé JJ, Staedel C. A functional selection of viral genetic elements in cultured cells to identify hepatitis C virus RNA translation inhibitors. Nucleic Acids Res, 2008, 36:e95. Machida K, Kondo Y, Huang J, Chen YC, Cheng KTH, Keck Z, Foung S, Dubuisson J, Sung VMH, Lai MMC. HCV-induced Immunoglobulin Hypermutation Reduces the Affinity and Neutralizing Activities of Antibodies against HCV Envelope Protein. J Virol, 2008, 82: Molina S, Castet V, Pichard-Garcia L, Wychowski C, Meurs E, Pascussi JM, Sureau C, Fabre JM, SaCunha A, Larrey D, Dubuisson J, Coste J, McKeating J, Maurel P, Fournier-Wirth C. Serum derived HCV infection of primary human hepatocytes is tetraspanin CD81 dependent. J Virol, 2008, 82: Rocha-Perugini V, Montpellier C, Delgrange D, Wychowski C, Helle F, Pillez A, Drobecq H, Le Naour F, Charrin S, Levy S, Rubinstein E, Dubuisson J, Cocquerel L. The CD81 partner EWI-2wint inhibits hepatitis C virus entry. PLoS ONE 3, 2008, e1866. Voisset C, Lavie M, Helle F, Op De Beeck A, Bilheu A, Bertrand-Michel J, Tercé F, Cocquerel L, Wychowski C, Vu-Dac N, Dubuisson J. Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits HCV entry. Cell Microbiol, 2008, 10: Voisset C, Weiss RA, Griffiths DJ. Human RNA "rumor" viruses : the search for novel human retroviruses in chronic disease. Microbiol Mol Biol Rev, 2008, 72: Antoine AF, Montpellier C, Cailliau K, Browaeys-Poly E, Vilain JP, Dubuisson J. The Alphavirus 6K protein activates endogenous ionic conductances when expressed in Xenopus oocytes. J Membr Biol, 2007, 215: Akazawa D, Date T, Morikawa K, Murayama A, Miyamoto M, Kaga M, Barth H,. Baumert T, Dubuisson J, Wakita T. CD81 expression is important for heterogeneous HCV permissiveness of Huh7 cell clones. J Virol, 2007, 81, Brochot E, Duverlie G, Castelain S, Morel V, Wychowski C, Dubuisson J, François C. Effect of ribavirin on the hepatitis C virus (JFH-1) and its correlation with interferon sensitivity. Antivir Ther, 2007, 12: Castelain S, Bonte D, Penin F, Francois C, Capron D, Dedeurwaerder S, Zawadzki P, Morel V, Wychowski C, Duverlie G. Hepatitis C Virus p7 membrane protein quasispecies variability in chronically infected patients treated with interferon and ribavirin, with or without amantadine. J Med Virol, 2007, 79:

4 Chapel C, Garcia C, Bartosh B, Roingeard P, Zitzmann N, Cosset FL, Dubuisson J, Dwek RA, Trépo C, Zoulim F, Durantel D. Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors. J Gen Virol, 2007, 88: Chevalier C, Saulnier A, Benureau Y, Flechet D, Delgrange D, Colbere-Garapin F, Wychowski C, Martin A. Inhibition of Hepatitis C Virus Infection in Cell Culture by Small Interfering RNAs. Mol Ther, 2007, 15: Ciczora Y, Callens N, Penin F, Pécheur EI, Dubuisson J. The transmembrane domains of HCV envelope glycoproteins: residues involved in E1E2 heterodimerization and involvement of these domains in virus entry. J Virol, 2007, 81: Couturier C, Sarkis C, Séron K, Belouzard S, Chen P, Lenain A, Corset L, Dam J, Vauthier V, Dubart A, Mallet J, Froguel P, Rouillé Y, Jockers R. Silencing of OB-RGRP in mouse hypothalamic arcuate nucleus increases leptin receptor signaling and prevents dietinduced obesity. Proc Natl Acad Sci USA, 2007, 104: Delgrange D, Pillez A, Castelain S, Cocquerel L, Rouillé Y, Dubuisson J, Wakita T, Duverlie G, Wychowski C. Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins. Gen Virol, 2007, 88: Dubuisson J. Hepatitis C virus proteins. World J Gastroenterol, 2007, 13: Duverlie G, Wychowski C. Cell culture systems for the hepatitis C virus. World J Gastroenterol, 2007, 13: Fournier C, Duverlie G, Francois C, Schnuriger A, Dedeurwaerder S, Brochot E, Capron D, Wychowski C, Thibault V, Castelain S. A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies. Virol J, 2007, 4:35. Gatignol A, Dubuisson J, Wainberg MA, Cohen EA, Jean-Luc Darlix JL. New pandemics: HIV and AIDS, HCV and chronic hepatitis, Influenza virus and flu. Retrovirology, 2007, 4:8. Helle F, Goffard A, Morel V, Duverlie G, McKeating J, Keck ZY, Foung S, Penin F, Dubuisson J, Voisset C. The neutralizing activity of anti-hcv antibodies is modulated by specific glycans on the E2 envelope protein. J Virol, 2007, 81: Johansson DX, Voisset C, Tarr AW, Aung M, Ball JK, Dubuison J, Persson M. Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus. Proc Natl. Acad Sci USA, 2007, 104: Lavie M, Goffard A, Dubuisson J. Assembly of a functional HCV glycoprotein heterodimer. Curr Issues Mol Biol, 2007, 9: PhD François HELLE Directeur de thèse : J Dubuisson "Les N-glycanes du Virus de l'hépatite C protègent contre la neutralisation mais sont une cible thérapeutique potentielle" 27 septembre 2007

5 David DELGRANGE Directeur de thèse : C Wychowski "Etude de la multiplication de la souche JFH-1 du virus de l hépatite C (VHC) en cellules Huh-7. Adaptation et sélection de mutations permettant une production rapide et massive du VHC. Localisation subcellulaire de protéines du VHC. Mise en évidence de clones cellulaires résistants à l infection par le VHC" 21 septembre 2007 Vera ROCHA Directeur de thèse : L Cocquerel "Identification d EWI-2wint, un partenaire de CD81 qui inhibie l entrée du VHC" 26 septembre 2007 HDR Ngoc VU-DAC "Rôle des lipoprotéines, transfert lipidique et mécanismes d entrée du VHC dans les hépatocytes" Laurence COQUEREL "Identification et caractérisation d'un inhibiteur de l entrée du virus de l'hépatite C" Karin SERON "Etude de différents aspects du trafic membranaire : de la levure Saccharomyces cerevisiae à l'obésité humaine"

Outline. Viruses. Discovery of Viruses. Nature of Viruses

Outline. Viruses. Discovery of Viruses. Nature of Viruses Viruses Outline The Discovery of Viruses The Nature & Structure of Viruses Bacteriophages Disease Viruses Virus Reproduction AIDS Virus Therapies Emerging Viruses Viruses and cancer Prions 1 Discovery

More information

The autophagy machinery is required to initiate hepatitis C virus infection. Marlène Dreux

The autophagy machinery is required to initiate hepatitis C virus infection. Marlène Dreux The autophagy machinery is required to initiate hepatitis C virus infection Marlène Dreux Hepatitis C virus life cycle HCV particles internalization RNA replication RNA translation ER HCV assembly and

More information

Microreview. Early steps of the hepatitis C virus life cycle

Microreview. Early steps of the hepatitis C virus life cycle Cellular Microbiology (2008) 10(4), 821 827 doi:10.1111/j.1462-5822.2007.01107.x First published online 3 January 2008 Microreview Early steps of the hepatitis C virus life cycle Jean Dubuisson,* François

More information

ANTIVIRAL AGENTS GENERAL PRINCIPLES. Viruses are parasitic, i.e. they utilize: Host metabolic enzymes Host ribosome for protein synthesis

ANTIVIRAL AGENTS GENERAL PRINCIPLES. Viruses are parasitic, i.e. they utilize: Host metabolic enzymes Host ribosome for protein synthesis ANTIVIRAL AGENTS GENERAL PRINCIPLES Viruses are parasitic, i.e. they utilize: Host metabolic enzymes Host ribosome for protein synthesis Structure of viruses Nucleic acid core: DNA or RNA Often contain

More information

Prospects for Vaccines against Hepatitis C Viruses. T. Jake Liang. M.D. Liver Diseases Branch NIDDK, NIH, HHS

Prospects for Vaccines against Hepatitis C Viruses. T. Jake Liang. M.D. Liver Diseases Branch NIDDK, NIH, HHS Prospects for Vaccines against Hepatitis C Viruses T. Jake Liang. M.D. Liver Diseases Branch NIDDK, NIH, HHS HCV Vaccine Prevention strategies Protective immunity Barriers and solutions Vaccine candidates

More information

AUCUN CONFLIT D'INTERET

AUCUN CONFLIT D'INTERET Lysophosphatidylcholine acyltransferase 1 () is downregulated by hepatitis C virus: impact on production of lipo-viro-particles Matthieu LEMASSON, Frauke BEILSTEIN, Véronique PENE, Sylvie DEMIGNOT & Arielle

More information

Hepatitis C Glossary of Terms

Hepatitis C Glossary of Terms Acute Hepatitis C A short-term illness that usually occurs within the first six months after someone is exposed to the hepatitis C virus (HCV). 1 Antibodies Proteins produced as part of the body s immune

More information

Translational Research in viral hepatitis: the French ANRS experience

Translational Research in viral hepatitis: the French ANRS experience ANRS HBV Cure Meeting June 17, 2014 Translational Research in viral hepatitis: the French ANRS experience Pr. Jean-François DELFRAISSY Director of ANRS Director of the Inserm / AVIESAN Institute for infectious

More information

Fat and Viral Liver Disease

Fat and Viral Liver Disease Fat and Viral Liver Disease Francesco Negro Viropathology Unit University of Geneva Medical Center Geneva, Switzerland Mainz, September 20, 2008 Steatosis and HBV Steatosis in HBV infection: prevalence

More information

Hepatitis C Monitoring and Complications (and Treatment!) Dr Mark Douglas

Hepatitis C Monitoring and Complications (and Treatment!) Dr Mark Douglas Hepatitis C Monitoring and Complications (and Treatment!) Dr Mark Douglas Hepatitis C Virus Shimizu et al., 1996 Positive single strand RNA virus Flaviviridae family, Hepacivirus genus 9.6 kbp genome ~3000

More information

Structure of viruses Categories of viruses: DNA and RNA-based Examples of viral diseases General anti-viral approaches

Structure of viruses Categories of viruses: DNA and RNA-based Examples of viral diseases General anti-viral approaches Anti-viral drugs General background Structure of viruses Categories of viruses: DNA and RNA-based Examples of viral diseases General anti-viral approaches Example 1: Targeting early stages of viral infection

More information

Acellular Biological Entities: Viruses, Viroids, & Prions

Acellular Biological Entities: Viruses, Viroids, & Prions Acellular Biological Entities: Viruses, Viroids, & Prions (Outline) Acellular entities as infectious agents of animal and plant diseases Structure and functional properties. Viral structural components:

More information

Viral Replication. I. Steps in Viral Replication. Scott M. Hammer

Viral Replication. I. Steps in Viral Replication. Scott M. Hammer Scott M. Hammer Viral Replication I. Steps in Viral Replication A. Attachment. This is the first step in viral replication. Surface proteins of the virus interact with specific receptors on the target

More information

Chapter 13 Viral Genetics

Chapter 13 Viral Genetics Chapter 13 Viral Genetics Viral Diseases Polio Hepatitis Measles Chicken pox Influenza: 1918 Epidemic 30-40 million deaths world-wide Smallpox Eradicated in 1976 vaccinations ceased in 1980 at risk population?

More information

Viruses. Some viruses also have an envelope made of protein, glycoproteins and lipids. The lipids are usually derived from their host cell.

Viruses. Some viruses also have an envelope made of protein, glycoproteins and lipids. The lipids are usually derived from their host cell. Viruses Viruses are non-living chemical entities. They are parasites of living cells. They are can replicate only within living cells by using the cell s enzyme systems. They have nucleic acid genomes,

More information

VIRAL STRUCTURE. Nucleic acid: Either DNA or RNA Single-stranded or double-stranded Linear or circular Segmented or non-segmented

VIRAL STRUCTURE. Nucleic acid: Either DNA or RNA Single-stranded or double-stranded Linear or circular Segmented or non-segmented VIRUSES non-cellular, obligately intracellular parasites replicate not by division characteristic intracellular life cycle (eclipse period) infectious genetic information VIRAL STRUCTURE Nucleic acid:

More information

Pathogens and the immune system

Pathogens and the immune system Review of lecture 7 Pathogens and the immune system Veronica Leautaud, Ph.D. vl2@ rice.edu BRC 511 / 530-lab Lecture 8 BIOE 301-Bioengineering and World Health Science Science is the human activity of

More information

Understanding Zika Virus Structure and Replication

Understanding Zika Virus Structure and Replication Understanding Zika Virus Structure and Replication Richard J. Kuhn, Ph.D. Purdue Institute of Inflammation, Immunology and Infectious Disease Purdue University NAS and IOM Zika Virus Workshop February

More information

Virus Replication. Virus-Infected Cells. Virus Replication. Microbiology Lecture 6. Virus Replication in Tissue Culture.

Virus Replication. Virus-Infected Cells. Virus Replication. Microbiology Lecture 6. Virus Replication in Tissue Culture. Virus Replication Microbiology Lecture 6 Professor T.J. Foster Virus Replication Can causes many different changes to host cells Cytopathic Effects (CPE) Altered shape Lysis Membrane fusion (giant cell

More information

Viruses. Viruses are non-living chemical entities. They are parasites of living cells. They are can replicate only within living cells by

Viruses. Viruses are non-living chemical entities. They are parasites of living cells. They are can replicate only within living cells by Viruses Viruses are non-living chemical entities. They are parasites of living cells. They are can replicate only within living cells by using the cell s enzyme systems. stems They have nucleic acid genomes,

More information

Chap Viruses

Chap Viruses Honors Biology Study Guide Viruses Name Chap 10.17 10.20 Viruses 1. Viruses are not considered living organisms; rather they are often referred to as acellular parasites. Explain. WHAT ARE THE THREE BASIC

More information

Lecture 2 Evolution in action: the HIV virus

Lecture 2 Evolution in action: the HIV virus Lecture 2 Evolution in action: the HIV virus The HIV/AIDS pandemic Life expectancy in Botswana What is HIV? What is HIV? HIV is a retrovirus (i.e., RNA-based) with 9 genes What is HIV? HIV is a retrovirus

More information

Human Genome Complexity, Viruses & Genetic Variability

Human Genome Complexity, Viruses & Genetic Variability Human Genome Complexity, Viruses & Genetic Variability (Learning Objectives) Learn the types of DNA sequences present in the Human Genome other than genes coding for functional proteins. Review what you

More information

Pathogens and the immune system

Pathogens and the immune system Pathogens and the immune system Veronica Leautaud, Ph.D. vl2@ rice.edu BRC 511 / 530-lab Lecture 8 BIOE 301-Bioengineering and World Health Review of lecture 7 Science Science is the human activity of

More information

Innovazione farmacologica e farmacologia clinica

Innovazione farmacologica e farmacologia clinica Innovazione farmacologica e farmacologia clinica Francesco Scaglione, MD, PhD Department of Medical Biotechnology and Translational Medicine School of medicine Postgradute School of clinical pharmacology

More information

WHY IS THIS IMPORTANT?

WHY IS THIS IMPORTANT? CHAPTER 12 THE STRUCTURE AND INFECTION CYCLE OF VIRUSES Eye of Science / Science Photo Library WHY IS THIS IMPORTANT? More than 80% of infectious diseases are caused by viruses. As a health professional,

More information

Viruses. Viral components: Capsid. Chapter 10: Viruses. Viral components: Nucleic Acid. Viral components: Envelope

Viruses. Viral components: Capsid. Chapter 10: Viruses. Viral components: Nucleic Acid. Viral components: Envelope Viruses Chapter 10: Viruses Lecture Exam #3 Wednesday, November 22 nd (This lecture WILL be on Exam #3) Dr. Amy Rogers Office Hours: MW 9-10 AM Too small to see with a light microscope Visible with electron

More information

CASL Symposium Hepatitis B Co-chairs: Carla Coffin and Mang Ma

CASL Symposium Hepatitis B Co-chairs: Carla Coffin and Mang Ma CASL Symposium Hepatitis B Co-chairs: Carla Coffin and Mang Ma Occult HBV Infection: Assessment and Clinical Significance D. Lorne Tyrrell Director, Li Ka Shing Institute of Virology University of Alberta

More information

The Treatment of Dengue Hemorrhagic Fever

The Treatment of Dengue Hemorrhagic Fever The Treatment of Dengue Hemorrhagic Fever James. A. Joyce Chairman & CEO Aethlon Medical, Inc. 3030 Bunker Hill Street San Diego, California 92109, USA www.aethlonmedical.com November 2, 2006 Summary Dengue

More information

Hepatitis. Objectives. General term for inflammation of the liver. Can be due to non-infectious causes such as:

Hepatitis. Objectives. General term for inflammation of the liver. Can be due to non-infectious causes such as: Laboratory Diagnosis & Monitoring of Infectious Hepatitis Objectives Compare and contrast the major types of hepatitis viruses and explain the disease transmission and progression processes in viral hepatitis

More information

1. Overview of Animal Viruses

1. Overview of Animal Viruses Chapter 13B: Animal Viruses 1. Overview of Animal Viruses 2. DNA Viruses 3. RNA Viruses 4. Prions 1. Overview of Animal Viruses Life Cycle of Animal Viruses The basic life cycle stages of animal viruses

More information

2. contain genetic material of DNA or RNA, but not both.

2. contain genetic material of DNA or RNA, but not both. Viruses 1. Viruses are -coated fragments of DNA or RNA that have become detached from the genomes of cells and have the ability to replicate themselves within cells. 2. contain genetic material of DNA

More information

Considerations for the Design and Conduct of Clinical Trials for Hepatitis C

Considerations for the Design and Conduct of Clinical Trials for Hepatitis C Considerations for the Design and Conduct of Clinical Trials for Hepatitis C www.ppdi.com Executive Summary Worldwide, up to 170 million people are chronically infected with the hepatitis C virus (HCV).

More information

ANTIVIRAL PREPARATIONS OF PLANT ORIGIN

ANTIVIRAL PREPARATIONS OF PLANT ORIGIN 1141 619: 578.831..,..,..,, e-mail: anpav_63@mail.ru - -. -.,.,.,., -, -,, -. :,, ANTIVIRAL PREPARATIONS OF PLANT ORIGIN Bogoyavlenskiy A.P., Turmagambetova A.S., Berezin V.E. Institute of Microbiology

More information

Co-infected health-care workers

Co-infected health-care workers Co-infected health-care workers Y.Yazdanpanah Service Universitaire des Maladies Infectieuses et du Voyageur C.H. Tourcoing, Faculté de Médecine de Lille CNRS U362, Lille, France Co-infected health-care

More information

TG1050, A NOVEL IMMUNOTHERAPEUTIC TO TREAT CHRONIC HEPATITIS B, CAN CONTROL HBsAg AND PROVOKE HBsAg SEROCONVERSION IN HBV-PERSISTENT MOUSE MODELS

TG1050, A NOVEL IMMUNOTHERAPEUTIC TO TREAT CHRONIC HEPATITIS B, CAN CONTROL HBsAg AND PROVOKE HBsAg SEROCONVERSION IN HBV-PERSISTENT MOUSE MODELS TG1050, A NOVEL IMMUNOTHERAPEUTIC TO TREAT CHRONIC HEPATITIS B, CAN CONTROL HBsAg AND PROVOKE HBsAg SEROCONVERSION IN HBV-PERSISTENT MOUSE MODELS Karine Lélu 1, Alexei Evlachev 1, Roland Kratzer 1, Sarah

More information

Opening Activity # 1: Opening Activity # 2: Latin Root Word #1: Latin Root Word #2: Review of Old Information: N/A New Information:

Opening Activity # 1: Opening Activity # 2: Latin Root Word #1: Latin Root Word #2: Review of Old Information: N/A New Information: Section: 1.4 Opening Activity # 1: Name: Opening Activity # 2: Latin Root Word #1: Latin Root Word #2: Review of Old Information: N/A New Information: Emerging Viruses: 1)West Nile Virus 2)HIV 3)Ebola

More information

Hepatitis C Vaccines: Are we making progress?

Hepatitis C Vaccines: Are we making progress? Hepatitis C Vaccines: Are we making progress? Second International Hepatitis Cure and Eradication Meeting. Vancouver November, 2015 Objectives: Review the need for a preventive vaccine in 2015. Identify

More information

RIBOSOME DISPLAY. in the absence of a stop codon.

RIBOSOME DISPLAY. in the absence of a stop codon. RIBOSOME C 6H A P T E R About the Image: This illustration depicts antibody-ribosome- (ARM) complexes, which have been used as display selection particles in an in vitro eukaryotic method for selection

More information

OZONE THERAPY FOR SSPE

OZONE THERAPY FOR SSPE OZONE THERAPY FOR SSPE Dr. Murat BAS OZONE CLINIC - BURSA, Turkey Translation from Turkish: B. Uluvar, Bursa 1 SSPE (subacute sclerosing panencephalitis) is one of the rarely seen side effects of the measles

More information

Replication of viruses An overview

Replication of viruses An overview Lec. 2 أ.د.فائزة عبذ اهلل مخلص Replication of viruses An overview Aim: Study the general steps in viral replication cycles. Objectives: 1. Viral growth curve 2. Stepwise description of specific events

More information

The neutralizing activity of anti-hcv antibodies is modulated by specific ACCEPTED. glycans on the E2 envelope protein

The neutralizing activity of anti-hcv antibodies is modulated by specific ACCEPTED. glycans on the E2 envelope protein JVI Accepts, published online ahead of print on May 00 J. Virol. doi:0./jvi.00-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved. Helle et al.

More information

Glossary of HIV/AIDS-Related Terms

Glossary of HIV/AIDS-Related Terms Chapter 48 Glossary of HIV/AIDS-Related Terms acquired immunodeficiency syndrome (AIDS): A disease of the body s immune system caused by the human immunodeficiency virus (HIV). AIDS is characterized by

More information

The Genetics of Viruses and Prokaryotes. A. Using Prokaryotes and Viruses for Genetic Experiments. The Genetics of Viruses and Prokaryotes

The Genetics of Viruses and Prokaryotes. A. Using Prokaryotes and Viruses for Genetic Experiments. The Genetics of Viruses and Prokaryotes Lecture Series 9 The Genetics of Viruses and Prokaryotes The Genetics of Viruses and Prokaryotes A. Using Prokaryotes and Viruses for Genetic Experiments C. Prokaryotes: Reproduction, Mutation, and The

More information

VIRUS STRUCUTRE VIRUS STRUCUTRE 29/06/2015 CHAPTER 12 THE STRUCTURE AND INFECTION CYCLE OF VIRUSES

VIRUS STRUCUTRE VIRUS STRUCUTRE 29/06/2015 CHAPTER 12 THE STRUCTURE AND INFECTION CYCLE OF VIRUSES CHAPTER 12 THE STRUCTURE AND INFECTION CYCLE OF VIRUSES VIRUS STRUCUTRE Viruses are obligate intracellular parasites because they cannot live outside a host cell Viruses come in a variety of sizes and

More information

Micro 301 Virology 10/22/12

Micro 301 Virology 10/22/12 Micro 301 Virology 10/22/12 Viral Structure Virion, protein capsid, some have lipid envelope Icosahedral, Helical, complex Genome: RNA or DNA, single or double stranded, + or sense, segmented or non-segmented

More information

Chapter 19: Viruses. AP Biology

Chapter 19: Viruses. AP Biology Chapter 19: Viruses AP Biology Overview: A Borrowed Life Viruses called bacteriophages can infect and set in motion a genetic takeover of bacteria, such as Escherichia coli Viruses lead a kind of borrowed

More information

Hing wars. During World War II, there was a series of hepatitis outbreaks

Hing wars. During World War II, there was a series of hepatitis outbreaks Hepatitis C: Toward a Cure and Eradication 1 CHARLES M. RICE Head, Laboratory of Virology and Infectious Disease Scientific and Executive Director Center for the Study of Hepatitis C Rockefeller University

More information

The role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015

The role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015 The role of IBV proteins in protection: cellular immune responses COST meeting WG2 + WG3 Budapest, Hungary, 2015 1 Presentation include: Laboratory results Literature summary Role of T cells in response

More information

6. Tolerance and regulaton

6. Tolerance and regulaton 1 2 Lecture outline Immunological tolerance and immune regulation -- 1 Abul K. Abbas UCSF Principles of immune regulation Self-tolerance; mechanisms of central and peripheral tolerance Inhibitory receptors

More information

7.013 Spring 2005 Problem Set 7 FRIDAY May 6th, 2005

7.013 Spring 2005 Problem Set 7 FRIDAY May 6th, 2005 MI Department of Biology 7.013: Introductory Biology - Spring 2005 Instructors: Professor Hazel Sive, Professor yler Jacks, Dr. Claudette Gardel Question 1 7.013 Spring 2005 Problem Set 7 RIDAY May 6th,

More information

Virus - genes on the move. Why is it difficult to treat viral disease with drugs? History. The origin of viruses

Virus - genes on the move. Why is it difficult to treat viral disease with drugs? History. The origin of viruses HIV A virion is the extracellular form of a virus and contains either an RNA or a DNA genome (Figure 9.1). The virus genome is introduced into a new host cell by infection. The virus redirects the host

More information

Viruses. Infectious particles (20-300nm) BIO162 Page Baluch

Viruses. Infectious particles (20-300nm) BIO162 Page Baluch Viruses BIO162 Page Baluch Microorganisms Cellular Acellular Virus, viroid, Prion Prokaryotes Domain Archaea & Bacteria Eukaryotes Domain Eucarya (Algae, Protozoa Fungi) Infectious particles (20-300nm)

More information

Influenza A viruses in humans this century

Influenza A viruses in humans this century Influenza A viruses in humans this century H1N1 H2N2 H3N2 Spanish Influenza Asian Influenza Hong Kong Influenza H1N1 1918 1957 1968 1977? Influenza A reservoir T l l l l T l l T 15 HA subtypes T l l T

More information

Viruses. The art of moving DNA around without sex. Pages:

Viruses. The art of moving DNA around without sex. Pages: Viruses The art of moving DNA around without sex Pages: 82 209-210 238-240 Viruses, too small to see with a light microscope (EM works though) Viruses are found everywhere (1 oz of sewage can contain 1

More information

Viral replication and genetics

Viral replication and genetics Viral replication and genetics Nabil A. NIMER Dept. Biotechnology & Genetic Engineering Faculty of Science Philadelphia University A virus enters the cell with nothing but its own puny molecule of nucleic

More information

Custom Antibody Services

Custom Antibody Services prosci-inc.com Custom Antibody Services High Performance Antibodies and More Broad Antibody Catalog Extensive Antibody Services CUSTOM ANTIBODY SERVICES Established in 1998, ProSci Incorporated is a leading

More information

Replicative cycle As obligate intracellular parasites, Virus must enter and replicate in living cells in order to reproduce themselves. This growth cy

Replicative cycle As obligate intracellular parasites, Virus must enter and replicate in living cells in order to reproduce themselves. This growth cy Replicative cycle As obligate intracellular parasites, Virus must enter and replicate in living cells in order to reproduce themselves. This growth cycle involves specific attachment of virus, penetration

More information

Is an HIV Vaccine Possible?

Is an HIV Vaccine Possible? Is an HIV Vaccine Possible? Prof. Omu Anzala KAVI Department of Medical Microbiology University of Nairobi Mechanism of Action Vaccines: Death Exposure Infection Disease Recovery Immune response to pathogens

More information

Chapter 6 - Virology. Structure. Size and morphology Capsid Envelope Complex Nucleic acid

Chapter 6 - Virology. Structure. Size and morphology Capsid Envelope Complex Nucleic acid Chapter 6 - Virology Topics Structure Classification Multiplication Cultivation and replication Nonviral infectious agent Teratogenic/Oncogenic - Viruses have a host range. That is, viruses infect specific

More information

Overview of Viruses. Dr. Angela M. Shaw Assistant Professor of Food Science and Human Nutrition Food Safety Extension and Outreach Specialist

Overview of Viruses. Dr. Angela M. Shaw Assistant Professor of Food Science and Human Nutrition Food Safety Extension and Outreach Specialist Overview of Viruses Dr. Angela M. Shaw Assistant Professor of Food Science and Human Nutrition Food Safety Extension and Outreach Specialist Viruses Dmitri Iwanowski - 1892 Experiments with tobacco plants

More information

KMS-Specialist & Customized Biosimilar Service

KMS-Specialist & Customized Biosimilar Service KMS-Specialist & Customized Biosimilar Service 1. Polyclonal Antibody Development Service KMS offering a variety of Polyclonal Antibody Services to fit your research and production needs. we develop polyclonal

More information

A novel polarized cell culture model to study HCV infection

A novel polarized cell culture model to study HCV infection A novel polarized cell culture model to study HCV infection Sandrine Belouzard Centre d Infection et d Immunité de Lille 15 ième réunion du réseau national hépatites Paris- 30 janvier 2015 HCV entry and

More information

NOVEL GENE SILECING TECHNOLOGY ANTISENSE-NUCLEASE CONJUGATES

NOVEL GENE SILECING TECHNOLOGY ANTISENSE-NUCLEASE CONJUGATES Antisense technology NOVEL GENE SILECING TECHNOLOGY ANTISENSE-NUCLEASE CONJUGATES Antisense technology is one of the most straightforward approaches for suppressing unwanted gene expression. Antisense

More information

What kind of evidence suggests that genes play a role in cancer?

What kind of evidence suggests that genes play a role in cancer? Genes and Cancer Cancer is really many diseases, all characterized by a lack of controlled cell division. What kind of evidence suggests that genes play a role in cancer? 1) Specific types of cancers seem

More information

Positive impact of HCV treatment initiation on health outcomes in injecting drug users

Positive impact of HCV treatment initiation on health outcomes in injecting drug users Positive impact of HCV treatment initiation on health outcomes in injecting drug users Perrine ROUX, PhD Substance Use Research Center, Columbia University, NY Inserm U912, SE4S, Marseille Introduction

More information

Viruses are most numerous microorganisms on the planet. Infect ALL types of cellular organisms

Viruses are most numerous microorganisms on the planet. Infect ALL types of cellular organisms 2 Small Pox Ebola filamentous form 60-80nm in diameter, on average 000 nm long (but highly variable) Chickenpox virus Polio Virus Influenza virus HIV virus Hepatitis this one actually Hepatits B magnified

More information

HIV life cycle: Targets for antivirals

HIV life cycle: Targets for antivirals HIV life cycle: Targets for antivirals Agents approved by FDA Likely to be available in the near future Tat Vif NRTI: Nucleoside Reverse Transcriptase Inhibitor NNRTI: Non-nucleoside Reverse Transcriptase

More information

The Need for a PARP in vivo Pharmacodynamic Assay

The Need for a PARP in vivo Pharmacodynamic Assay The Need for a PARP in vivo Pharmacodynamic Assay Jay George, Ph.D., Chief Scientific Officer, Trevigen, Inc., Gaithersburg, MD For further infomation, please contact: William Booth, Ph.D. Tel: +44 (0)1235

More information

HIV viral structure. Human Immunodeficiency Virus type 1 (HIV-1) The etiologic agent of acquired immunodeficiency

HIV viral structure. Human Immunodeficiency Virus type 1 (HIV-1) The etiologic agent of acquired immunodeficiency Immunology and AIDS Human Immunodeficiency Virus type 1 (HIV-1) The etiologic agent of acquired immunodeficiency syndrome (AIDS) Probably originated in Sub-saharan Africa after crossing species barrier

More information

Source:

Source: Novel Influenza H1N1 Joseph C. Frantz, Ph.D. Director, Pharmaceutical Technology Sanofi Pasteur, Swiftwater, PA Lecture Outline Origins of a virus Microbiology of the virus Viruses and human disease Influenza

More information

Bioinformatics. Viruses, etc

Bioinformatics. Viruses, etc Bioinformatics, etc David Gilbert Bioinformatics Research Centre www.brc.dcs.gla.ac.uk Department of Computing Science, University of Glasgow Incorporating notes by Ali Al-Shahib, David Leader, and Wikipaedia

More information

Hepatitis C Virus Inactivation

Hepatitis C Virus Inactivation Hepatitis C Virus Inactivation PD Dr. Eike Steinmann Centre for Experimental and Clinical Infection Research Institute of Experimental Virology, Twincore* *joint venture between Medical School Hannover

More information

EVALUATING NEW ANTIVIRAL AND ANTIBIOTIC DRUG CANDIDATES. Advancing your journey from discovery to post-marketing

EVALUATING NEW ANTIVIRAL AND ANTIBIOTIC DRUG CANDIDATES. Advancing your journey from discovery to post-marketing EVALUATING NEW ANTIVIRAL AND ANTIBIOTIC DRUG CANDIDATES Advancing your journey from discovery to post-marketing SUMMARY The development of anti-infective treatments to combat illnesses caused by viral

More information

The Insulin-like Growth Factor 1 Receptor Pathway in Cancer

The Insulin-like Growth Factor 1 Receptor Pathway in Cancer IGF2 IGF1 The Insulin-like Growth Factor 1 Receptor Pathway in Cancer An Overview: The Pathway Is Necessary for Normal Growth and Tumorigenesis and Represents a Potential Target for Anticancer Therapy

More information

Microbiology Lecture 5

Microbiology Lecture 5 Microbiology Lecture 5 Structure of Viruses Professor T.J. Foster Relative Sizes of Viruses, Bacterial and Mammalian Cells Infectious agents Viruses DNA or RNA genomes Nucleic acid protected by protein

More information

Mid-Clinical Stage Antiviral Drug Development Company

Mid-Clinical Stage Antiviral Drug Development Company BIOTRON LIMITED (ASX:BIT) Mid-Clinical Stage Antiviral Drug Development Company Investor Update 20 August 2015 Dr Michelle Miller Managing Director +61 412 313329 mmiller@biotron.com.au www.biotron.com.au

More information

VOCABULARY. Virus Capsid Envelope Human Immunodeficiency Virus (HIV) Influenza. Lytic Cycle Lysogenic Cycle Lysis Retrovirus

VOCABULARY. Virus Capsid Envelope Human Immunodeficiency Virus (HIV) Influenza. Lytic Cycle Lysogenic Cycle Lysis Retrovirus Viruses TEKS Compare the structures of viruses to cells, describe viral reproduction, and describe the role of viruses in causing disease such as Human Immunodeficiency Virus (HIV) and influenza VOCABULARY

More information

The immunogenic vaccine against HCV and HBV

The immunogenic vaccine against HCV and HBV National Centre for Research and Development, The immunogenic vaccine against HCV and HBV Katarzyna Grzyb Laboratory of Virus Molecular Biology Intercollegate Faculty of Biotechnology UG-MUG 1 Hepatitis

More information

TREATMENT OF GENETIC DISEASES. Dr Neda Bogari

TREATMENT OF GENETIC DISEASES. Dr Neda Bogari TREATMENT OF GENETIC DISEASES Dr Neda Bogari INTRODUCTION Many genetic disorders characterized by progressive phenotype with no effective treatment available at the present. The most promising hope in

More information

BBS2711 Virology RESPIRATORY VIRUSES. Dr Paul Young, Department of Microbiology & Parasitology. Respiratory Viruses

BBS2711 Virology RESPIRATORY VIRUSES. Dr Paul Young, Department of Microbiology & Parasitology. Respiratory Viruses BBS2711 Virology RESPIRATORY VIRUSES Dr Paul Young, Department of Microbiology & Parasitology. p.young@mailbox.uq.edu.au Respiratory Viruses Respiratory tract is major route of invasion for a wide range

More information

Hepatitis C virus (HCV), a small enveloped RNA virus of the

Hepatitis C virus (HCV), a small enveloped RNA virus of the Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus Rodney S. Russell*, Jean-Christophe Meunier*, Shingo Takikawa*, Kristina Faulk*, Ronald E. Engle*,

More information

Virus Replication. I- Viral Growth Curve

Virus Replication. I- Viral Growth Curve Virus Replication The viral replication cycle is described in two different ways. The first approach is a growth curve, which shows the amount of virus produced at different times after infection. The

More information

Antiviral Drugs. Chapters 10, 13, 11: Antiviral therapy Parasites. Antiviral drugs: Nucleoside analogs. Antiviral drugs: #1. Nucleoside analogs

Antiviral Drugs. Chapters 10, 13, 11: Antiviral therapy Parasites. Antiviral drugs: Nucleoside analogs. Antiviral drugs: #1. Nucleoside analogs Antiviral Drugs Chapters 10, 13, 11: Antiviral therapy Parasites Bio 139 Dr. Amy Rogers Fundamental problem: How can a drug be selectively toxic against viruses, which are acellular life forms which depend

More information

Guidance for Industry Antiviral Product Development Conducting and Submitting Virology Studies to the Agency

Guidance for Industry Antiviral Product Development Conducting and Submitting Virology Studies to the Agency Guidance for Industry Antiviral Product Development Conducting and Submitting Virology Studies to the Agency U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation

More information

TRANSGENE SA, FRANCE 2. INSTITUT PASTEUR, FRANCE On behalf. AFEF 2013, Lille 02 nd October 2013

TRANSGENE SA, FRANCE 2. INSTITUT PASTEUR, FRANCE On behalf. AFEF 2013, Lille 02 nd October 2013 A MULTIVALENT ADENOVIRUS-BASED IMMUNOTHERAPEUTIC FOR TREATMENT OF CHRONIC HEPATITIS B INDUCES BROAD, ROBUST AND POLYFUNCTIONAL T CELLS IN NAIVE MICE AND EXERT AN EARLY ANTIVIRAL EFFECT IN HBV TOLERANT

More information

Attachment and Entry of Viruses

Attachment and Entry of Viruses Attachment and Entry of Viruses Contact: Dr. Eike Steinmann Centre for Experimental and Clinical Infection Research Department of Experimental Virology, Twincore Feodor-Lynen-Str. 7, 30625 Hannover Tel.:

More information

AP BIOLOGY Cells Activity #6 VIRUSES LIFE OF A VIRUS ANATOMY OF A VIRUS. Cell Activity #6 Page 1 of 9

AP BIOLOGY Cells Activity #6 VIRUSES LIFE OF A VIRUS ANATOMY OF A VIRUS. Cell Activity #6 Page 1 of 9 AP BIOLOGY Cells Activity #6 LIFE OF A VIRUS VIRUSES ANATOMY OF A VIRUS Cell Activity #6 Page 1 of 9 REPLICATION CYCLES FOR DNA VIRUSES LYTIC CYCLE LYSOGENIC CYCLE Cell Activity #6 Page 2 of 9 RNA VIRUSES

More information

MedChem 401 RNA Viruses. RNA Viruses

MedChem 401 RNA Viruses. RNA Viruses MedChem 401 RNA Viruses These viruses contain a genome composed of RNA Remember plus-sense vs. minus-sense RNA genomes Remember RNA-dependent RNA polymerases (RDRP) RNA viruses typically have small genomes,

More information

HIV Infection. Laboratory diagnosis and monitoring Philip Cunningham NSW State Reference Laboratory for HIV/AIDS St Vincent s Hospital Sydney

HIV Infection. Laboratory diagnosis and monitoring Philip Cunningham NSW State Reference Laboratory for HIV/AIDS St Vincent s Hospital Sydney HIV Infection Laboratory diagnosis and monitoring 2006 Philip Cunningham NSW State Reference Laboratory for HIV/AIDS St Vincent s Hospital Sydney HIV laboratory tests diagnosis of infection acute, recent,

More information

Liver Disease and Therapy of Hepatitis B Virus Infections

Liver Disease and Therapy of Hepatitis B Virus Infections Liver Disease and Therapy of Hepatitis B Virus Infections University of Adelaide Catherine Scougall Arend Grosse Huey-Chi Low Allison Jilbert Fox Chase Cancer Center Chunxiao Xu Carol Aldrich Sam Litwin

More information

Foundations in Microbiology Seventh Edition

Foundations in Microbiology Seventh Edition Lecture PowerPoint to accompany Foundations in Microbiology Seventh Edition Talaro Chapter 12 Drugs, Microbes, Host The Elements of Chemotherapy Copyright The McGraw-Hill Companies, Inc. Permission required

More information

Viruses 11/30/2015. Chapter 19. Key Concepts in Chapter 19

Viruses 11/30/2015. Chapter 19. Key Concepts in Chapter 19 Chapter 19 Viruses Dr. Wendy Sera Houston Community College Biology 1406 Key Concepts in Chapter 19 1. A virus consists of a nucleic acid surrounded by a protein coat. 2. Viruses replicate only in host

More information

Introduction. Genetic variability a major challenge for vaccine development. Abstract Summary

Introduction. Genetic variability a major challenge for vaccine development. Abstract Summary Development of hepatitis C virus vaccines: challenges and progress 1 2 * Françoise Stoll-Keller, Heidi Barth 3, Samira Fafi-Kremer 1 2, Mirjam B. Zeisel 1, Thomas F. Baumert 1 4 1 Interaction virus-hôte

More information

Viruses Obligate Intracellular Parasites

Viruses Obligate Intracellular Parasites Viruses Obligate Intracellular Parasites Virus Particle (Virion) protect genome facilitate entry Replication--1 virus can yield 10-100,000 progeny Lecture 1 Introduction/history of virology Lecture 2 vertebrate

More information

Lesson Overview. Studying the Human Genome. Lesson Overview Viruses

Lesson Overview. Studying the Human Genome. Lesson Overview Viruses Lesson Overview 20.1 Viruses THINK ABOUT IT Imagine that farmers have begun to lose their tobacco crop to a plant disease. To determine what is causing the disease, you take leaves from a diseased plant

More information

Identification of T-cell epitopes of SARS-coronavirus for development of peptide-based vaccines and cellular immunity assessment methods

Identification of T-cell epitopes of SARS-coronavirus for development of peptide-based vaccines and cellular immunity assessment methods RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES PKS Chan 陳 基 湘 S Ma 文 子 光 SM Ngai 倪 世 明 Key Messages 1. Subjects recovered from SARS-CoV infection retain memory of cellular immune response to epitopes

More information

VIRUSES. Viruses are not classified in any kingdom yet because they are not really alive. They only show signs of life after they infect a host cell.

VIRUSES. Viruses are not classified in any kingdom yet because they are not really alive. They only show signs of life after they infect a host cell. VIRUSES Viruses are not classified in any kingdom yet because they are not really alive. They only show signs of life after they infect a host cell. Virus: lifeless particle that does not carry out any

More information